Sensormedics has an unrivalled connection with the respiratory market in Europe and an amazing passion to deliver on results. With our commencement of clinical studies in multiple countries, the timing for a partner like Sensormedics to come on board.
Cambridge, CAMBS (PRWEB UK) 4 November 2013
PneumaCare (Cambridge, UK) is pleased to announce the appointment of Sensormedics Italia as their master distributor in Europe for their breakthrough Structured Light Plethysmography (SLP) technology.
With their 29 years of medical device experience in the cardiopulmonary sector and a well-established network of business and clinical contacts, PneumaCare expects a rapid introduction of its PneumaScan™ and Thora3DI™ product into key hospitals across Europe.
Eric Stewart, PneumaCare's Commercial Director, stated that “Sensormedics has an unrivalled connection with the respiratory market in Europe and an amazing passion to deliver on results. With PneumaCare's commencement of clinical studies in multiple countries, the timing for a partner like Sensormedics to come on board is perfect.”
Sensormedics will coordinate all distribution and sales activities through their network of distributors in the countries below and manage the Italian market directly through their Italian distribution operations.
"It is a very exciting moment for our company history but even more for the whole global medical device market," stated Roby Perissin, General Manager of Sensormedics Italia.
“We have evaluated the PneumaCare product for many months prior to this agreement with PneumaCare and found an extremely high level of interest for this innovative, non-invasive method of clinical evaluation. The Thora3DI™ product enables clinicians to evaluate patient respiratory status and breathing pattern and response to treatment. The PneumaCare systems are highly enabling for many specialists, from the pediatrician to the pulmonary physician involved in, ventilated patients, into several areas of rehabilitation, pre and post surgery assessment and other areas. This will be a product that will quickly gain importance not only into the research areas but even more into the real clinical world because it is seen as something very useful, if not essential, to address these patients' assessment needs".
PneumaCare will continue to work directly with Sensormedics and their partners to support the company’s products in the field and clinical activities in the market.
About Sensormedics Italia
Headquartered in Milan since being founded in 1984, Sensormedics has a network of 17 regional offices/distributors that ensure the finest sales and service support in the industry. Sensormedics Italia is a market leader in Italy and a leading distributor worldwide for pulmonary function, cardiopulmonary exercise equipment systems, sleep diagnostic devices, respiratory mechanics and asthma allergy monitoring devises.
PneumaCare is a Cambridge (UK) based company, developing and marketing revolutionary non-contact, non-invasive respiratory imaging systems that allow the user to better understand respiratory function. Their premier product, the Thora-3DI™, is an imaging and assessment device utilising novel non-contact 3D-imaging technology. This breakthrough in patient care is presently operating in a range of hospital environments from paediatrics to surgical assessment and adult intensive care.
For more information about this partnership or PneumaCare’s products and technologies, please contact us at:
Mark Harwood – Chief Executive Officer
Eric Stewart – Commercial Director
St John’s Innovation Centre
Cambridge UK CB4 0WS
Tel: +44 1223 703 151